Macquarie Group
ELAN icon

Macquarie Group’s Elanco Animal Health ELAN Stock Holding History

Macquarie Group’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-103,769
Closed -$2.09M – 1049
2025
Q3 		$2.09M Buy
+103,769
New +$1.74M ﹤0.01% 1159
2024
Q4 		– Sell
-55,008
Closed -$808K – 1675
2024
Q3 		$808K Sell
55,008
-20,319
-27% -$283K ﹤0.01% 1415
2024
Q2 		$1.09M Buy
+75,327
New +$1.2M ﹤0.01% 1363
2023
Q2 		– Sell
-13,384
Closed -$126K – 1678
2023
Q1 		$126K Hold
13,384
– – ﹤0.01% 1594
2022
Q4 		$164K Buy
13,384
+7,046
+111% +$87.8K ﹤0.01% 1617
2022
Q3 		$79K Sell
6,338
-20
-0.3% -$350 ﹤0.01% 1828
2022
Q2 		$125K Sell
6,358
-2,780
-30% -$65.8K ﹤0.01% 1812
2022
Q1 		$239K Buy
9,138
+1,606
+21% +$42.8K ﹤0.01% 1776
2021
Q4 		$214K Sell
7,532
-614,115
-99% -$19.1M ﹤0.01% 1750
2021
Q3 		$19.8M Buy
621,647
+1,786
+0.3% +$59.9K 0.02% 770
2021
Q2 		$21.5M Buy
619,861
+599,579
+2,956% +$19.8M 0.02% 763
2021
Q1 		$597K Sell
20,282
-47,052
-70% -$1.45M ﹤0.01% 1500
2020
Q4 		$2.06M Buy
67,334
+47,436
+238% +$1.45M ﹤0.01% 1090
2020
Q3 		$556K Buy
19,898
+4,806
+32% +$122K ﹤0.01% 1379
2020
Q2 		$324K Sell
15,092
-2,828
-16% -$62.5K ﹤0.01% 1439
2020
Q1 		$401K Buy
17,920
+2,569
+17% +$70.4K ﹤0.01% 1319
2019
Q4 		$452K Buy
15,351
+6,450
+72% +$175K ﹤0.01% 1424
2019
Q3 		$237K Sell
8,901
-11,287
-56% -$339K ﹤0.01% 1538
2019
Q2 		$683K Sell
20,188
-278,821
-93% -$9.05M ﹤0.01% 1299
2019
Q1 		$9.59M Buy
299,009
+185,107
+163% +$5.7M 0.02% 628
2018
Q4 		$3.59M Buy
113,902
+13,902
+14% +$455K 0.01% 832
2018
Q3 		$3.49M Buy
+100,000
New +$3.52M 0.01% 853

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Macquarie Group's ELAN Position: Q4 2025 in Review

Macquarie Group sold out of Elanco Animal Health (ELAN) in Q4 2025, closing a stake of 103,769 shares — an estimated $2.09M sold.

Macquarie Group first reported a position in ELAN in Q3 2018 and held it in 22 quarters. The position peaked at $21.5M in Q2 2021. 485 funds tracked by Wall St. Rank hold ELAN as of Q4 2025.

  • Macquarie Group reported no remaining Elanco Animal Health position as of Q4 2025 after selling out during the quarter.
  • Macquarie Group sold 103,769 Elanco Animal Health shares in Q4 2025, an estimated $2.09M.
  • Macquarie Group first reported a position in Elanco Animal Health in Q3 2018 and held it in 22 quarters.
  • Macquarie Group's Elanco Animal Health position peaked at $21.5M in Q2 2021.
  • 485 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.